pain; generalised joint pains; i mostly walked a 7km run as i couldn't lift my legs up without pain to complete my strides; pain in my gluteus maximus; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority. the reporter is the patient. regulatory number: gb-mhra-webcovid-202202181557510240-6uaqq. other case identifier(s): gb-mhra-adr 26621462. a 46 year-old female patient (not pregnant) received bnt162b2 (bnt162b2), administration date 16jan2021 (lot number: el0739) as dose 1, single for covid-19 immunisation. relevant medical history included: "arthritis" (unspecified if ongoing); "psoriatic arthritis" (unspecified if ongoing); "rheumatoid arthritis" (unspecified if ongoing), notes: taking regular medicines for rheumatoid arthritis (or other types of arthritis except osteoarthr... concomitant medication(s) included: bristol taken for psoriatic arthropathy, start date: 04apr2021; crescent pharma folic acid taken for psoriatic arthropathy, start date: 17may2021; etoricoxib taken for psoriatic arthropathy, start date: 28apr2021; methotrexate taken for psoriatic arthropathy, start date: 17may2021; teva omeprazole taken for psoriatic arthropathy, start date: 12apr2021. the following information was reported: pain (disability, medically significant), outcome "not recovered", described as "pain"; arthralgia (disability, medically significant) with onset 16feb2021, outcome "not recovered", described as "generalised joint pains"; myalgia (disability, medically significant) with onset feb2021, outcome "unknown", described as "pain in my gluteus maximus"; pain in extremity (disability, medically significant) with onset 16feb2021, outcome "unknown", described as "i mostly walked a 7km run as i couldn't lift my legs up without pain to complete my strides". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (unspecified date) negative, notes: no - negative covid-19 test; x-ray: (mar2021) unknown results, notes: to identify why the pain had gone to different locations bilaterally hips and shoulders. no follow-up attempts are possible. no further information is expected.; sender's comments: linked report(s) : gb-pfizer inc-202200322650 same patient/vaccine different dose/event (dose 2)

test name: covid-19 virus test; test result: negative ; comments: no - negative covid-19 test; test date: 202103; test name: x-ray; result unstructured data: test result:unknown results; comments: to identify why the pain had gone to different locations bilaterally hips and shoulders

na

na